Franklin Okumu
CTO and Co-Founder
Franklin Okumu is an accomplished biotechnology executive with over 15 years of experience driving innovation and growth in the pharmaceutical industry. As the CTO and Co-Founder of Owl Therapeutics, he is responsible for leading the company's technology strategy, overseeing research and development, and championing the development of novel therapeutic solutions.
Professional Overview
With a strong background in drug discovery and development, Franklin leverages his extensive technical expertise and entrepreneurial mindset to spearhead the creation of cutting-edge therapeutics. He is a recognized expert in the fields of biopharmaceuticals, drug delivery systems, and precision medicine, consistently delivering measurable impact through his leadership.
Current Role
In his role as CTO and Co-Founder of Owl Therapeutics, Franklin is responsible for driving the company's technology roadmap, managing R&D initiatives, and overseeing the development of the organization's proprietary drug platforms. Under his guidance, Owl Therapeutics has made significant strides in advancing its portfolio of innovative therapies, positioning the company as a leader in the biotechnology industry.
Career Progression
Prior to co-founding Owl Therapeutics, Franklin served as the Executive Advisor and CTO at Armis Biopharma, where he played a pivotal role in the company's strategic planning and technology development. He also held the position of President and Chief Scientific Officer at EVO Pharmaceuticals Inc., where he led the company's research efforts and contributed to the successful commercialization of several drug products.
Earlier in his career, Franklin served as the Vice President at Dr. Reddy's Laboratories and as a Principal Scientist at Novo Nordisk A/S, where he gained extensive experience in drug discovery, formulation development, and clinical trial management.
Academic Background
Franklin holds a Ph.D. in Pharmaceutical Sciences from the University of Maryland, Baltimore, with a specialization in drug delivery and pharmacokinetics. He has published numerous peer-reviewed articles in prestigious scientific journals and has been recognized for his innovative contributions to the field of pharmaceutical research.
Areas of Expertise
- Biopharmaceutical drug discovery and development
- Innovative drug delivery systems and formulations
- Precision medicine and personalized therapeutics
- Biotechnology strategy and technology roadmapping
- Cross-functional team leadership and project management
Professional Impact
Throughout his career, Franklin has demonstrated a track record of driving transformative change and delivering substantial results. His leadership has been instrumental in the successful development and commercialization of several drug products, and he has made significant contributions to the advancement of the biotechnology industry.
Conclusion
Franklin Okumu is a visionary biotechnology leader with a proven ability to translate scientific innovation into tangible business value. As the CTO and Co-Founder of Owl Therapeutics, he is poised to continue his impactful journey, driving the development of cutting-edge therapeutic solutions that will positively transform the lives of patients worldwide.
